Ticker Details
Zai Lab Limited Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.09B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.16 | 2.43%
Avg Daily Range (30 D):	$0.47 | 2.21%
Avg Daily Range (90 D):	$0.35 | 1.80%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.63M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	3,497
Avg Institutional Trade:	$2.5M
Avg Institutional Trade (30 D):	$2.28M
Avg Institutional Trade (90 D):	$1.76M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.59M
Avg Closing Trade (30 D):	$1.71M
Avg Closing Trade (90 D):	$1.49M
Avg Closing Volume:	51.82K

News

Apr 15, 2026 @ 12:00 PM Boehringer Ingelheim and Zai Lab announce Collabor... Source: Na

Feb 5, 2026 @ 2:35 PM $207B Market Shift: The Race for Fast Track Approv... Source: Prnewswire

Sep 11, 2025 @ 12:02 PM Zai Lab's Double Whammy: Earnings Miss, Phase 3 Se... Source: Bamboo Works Benzinga Contributor

Jul 16, 2025 @ 10:51 PM Cancer Pipeline Milestones Coming Fast as Regulato... Source: Prnewswire

Jul 7, 2025 @ 5:00 PM Bispecific Antibody Clinical Trial Pipeline Gains ... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.17	$-.05	$-.05
Diluted EPS	$-.17	$-.05	$-.05
Revenue	$453.28M	$99.61M	$127.6M
Gross Profit	$262.9M	$61.3M	$65.3M
Net Income / Loss	$-178.12M	$-51.02M	$-50.41M
Operating Income / Loss	$-242.51M	$-69.39M	$-69.41M
Cost of Revenue	$190.38M	$38.32M	$62.3M
Net Cash Flow	$-106.77M	$-28.63M	$-37.75M
PE Ratio